RICHARDSON; Celeste

Patent Applications and Registrations

Patent applications and USPTO patent grants for RICHARDSON; Celeste.The latest application filed is for "cd40l compositions and methods for tunable regulation".

Company Profile

7.7.17

RICHARDSON; Celeste - Brookline MA
Richardson; Celeste - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cd40l Compositions And Methods For Tunable Regulation App 20220175781 - SCHEBESTA; Michael ; et al.	2022-06-09
Cellular Therapeutics Engineered With Signal Modulators And Methods Of Use Thereof App 20220162288 - Richardson; Celeste ; et al.	2022-05-26
Treatment Of Cancer Using Humanized Anti-bcma Chimeric Antigen Receptor App 20220064316 - Brogdon; Jennifer ; et al.	2022-03-03
PDE5 compositions and methods for immunotherapy Grant 11,241,485 - Suri , et al. February 8, 2	2022-02-08
Er Tunable Protein Regulation App 20210386788 - SURI; Vipin ; et al.	2021-12-16
Anti-BCMA chimeric antigen receptor Grant 11,084,880 - Brogdon , et al. August 10, 2	2021-08-10
CA2 compositions and methods for tunable regulation Grant 11,058,725 - Elpek , et al. July 13, 2	2021-07-13
Treatment Of Cancer Using A Cd33 Chimeric Antigen Receptor App 20210139595 - Ebersbach; Hilmar Erhard ; et al.	2021-05-13
Ca2 Compositions And Methods For Tunable Regulation App 20210069248 - ELPEK; Kutlu Goksu ; et al.	2021-03-11
Treatment of cancer using a CD33 chimeric antigen receptor Grant 10,851,166 - Ebersbach , et al. December 1, 2	2020-12-01
Treatment Of Cancer Using A Cll-1 Chimeric Antigen Receptor App 20200215171 - Brogdon; Jennifer ; et al.	2020-07-09
Pde5 Compositions And Methods For Immunotherapy App 20200101142 - SURI; Vipin ; et al.	2020-04-02
Treatment of cancer using a CLL-1 chimeric antigen receptor Grant 10,568,947 - Brogdon , et al. Feb	2020-02-25
Treatment Of Cancer Using 5 Humanized Anti-bcma Chimeric Antigen Receptor App 20190153061 - Brogdon; Jennifer ; et al.	2019-05-23
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor Grant 10,174,095 - Brogdon , et al. J	2019-01-08
Compositions And Methods For Immunooncology App 20180362975 - CHEN; Ming-Wei ; et al.	2018-12-20
Treatment Of Cancer Using A Cd33 Chimeric Antigen Receptor App 20180044423 - Ebersbach; Hilmar Erhard ; et al.	2018-02-15
Treatment of cancer using a CD33 chimeric antigen receptor Grant 9,777,061 - Ebersbach , et al. October 3, 2	2017-10-03
Treatment Of Cancer Using A Cd33 Chimeric Antigen Receptor App 20160096892 - Brogdon; Jennifer ; et al.	2016-04-07
Treatment Of Cancer Using A Cll-1 Chimeric Antigen Receptor App 20160051651 - Brogdon; Jennifer ; et al.	2016-02-25
Treatment Of Cancer Using Humanized Anti-bcma Chimeric Antigen Receptor App 20160046724 - Brogdon; Jennifer ; et al.	2016-02-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.